These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33024450)

  • 1. Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure.
    Sadlonova M; Meyer T; Binder L; Wachter R; Edelmann F; Herrmann-Lingen C
    Biopsychosoc Med; 2020; 14():24. PubMed ID: 33024450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.
    Sadlonova M; Meyer T; Binder L; Wachter R; Edelmann F; Herrmann-Lingen C
    Psychoneuroendocrinology; 2019 Mar; 101():272-277. PubMed ID: 30594111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
    Meyer T; Herrrmann-Lingen C; Chavanon ML; Nolte K; Pasedach CA; Binder L; Pieske B; Hasenfuss G; Wachter R; Edelmann F
    Clin Res Cardiol; 2015 Jul; 104(7):574-81. PubMed ID: 25665711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors.
    Meyer T; Herrmann-Lingen C; Chavanon ML; Pieske B; Wachter R; Edelmann F
    Psychoneuroendocrinology; 2015 Dec; 62():227-32. PubMed ID: 26342564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure.
    Atabakhshian R; Kazerouni F; Raygan F; Amirrasouli H; Rahimipour A; Shakeri N
    Int Cardiovasc Res J; 2014 Dec; 8(4):143-7. PubMed ID: 25614856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
    Edelmann F; Holzendorf V; Wachter R; Nolte K; Schmidt AG; Kraigher-Krainer E; Duvinage A; Unkelbach I; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Stough WG; Pieske BM
    Eur J Heart Fail; 2015 Feb; 17(2):214-23. PubMed ID: 25418979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
    George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.
    Meyer T; Chavanon ML; Herrrmann-Lingen C; Roggenthien M; Nolte K; Pieske B; Wachter R; Edelmann F
    PLoS One; 2015; 10(8):e0136739. PubMed ID: 26322793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Galectin-3 in Chronic Heart Failure: A Case-Control Study.
    Khadeja Bi A; Santhosh V; Sigamani K
    Cureus; 2022 Aug; 14(8):e28310. PubMed ID: 36158385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
    Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
    Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
    Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
    Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
    Srivatsan V; George M; Shanmugam E
    Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
    AbouEzzeddine OF; Haines P; Stevens S; Nativi-Nicolau J; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    JACC Heart Fail; 2015 Mar; 3(3):245-52. PubMed ID: 25742762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
    Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
    JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of health-related quality of life at baseline in predicting event-free survival in patients with a cardiovascular risk profile].
    Beismann C; Nolte K; Wachter R; Hashemi D; Trippel T; Edelmann F; Meyer T
    Z Psychosom Med Psychother; 2021 Dec; 67(4):361-380. PubMed ID: 34904553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.
    Gopal DM; Kommineni M; Ayalon N; Koelbl C; Ayalon R; Biolo A; Dember LM; Downing J; Siwik DA; Liang CS; Colucci WS
    J Am Heart Assoc; 2012 Oct; 1(5):e000760. PubMed ID: 23316284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.
    Lok DJ; Van Der Meer P; de la Porte PW; Lipsic E; Van Wijngaarden J; Hillege HL; van Veldhuisen DJ
    Clin Res Cardiol; 2010 May; 99(5):323-8. PubMed ID: 20130888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.
    Meijers WC; Januzzi JL; deFilippi C; Adourian AS; Shah SJ; van Veldhuisen DJ; de Boer RA
    Am Heart J; 2014 Jun; 167(6):853-60.e4. PubMed ID: 24890535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
    Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.